Protective Heterologous Antiviral Immunity and Enhanced Immunopathogenesis Mediated by Memory T Cell Populations
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
A basic principle of immunology is that prior immunity results in complete protection against a homologous agent. In this study, we show that memory T cells specific to unrelated viruses may alter the host's primary immune response to a second virus. Studies with a panel of heterologous viruses, including lymphocytic choriomeningitis (LCMV), Pichinde (PV), vaccinia (VV), and murine cytomegalo (MCMV) viruses showed that prior immunity with one of these viruses in many cases enhanced clearance of a second unrelated virus early in infection. Such protective immunity was common, but it depended on the virus sequence and was not necessarily reciprocal. Cell transfer studies showed that both CD4 and CD8 T cell populations from LCMV-immune mice were required to transfer protective immunity to naive hosts challenged with PV or VV. In the case of LCMV-immune versus naive mice challenged with VV, there was an enhanced early recruitment of memory phenotype interferon (IFN) γ–secreting CD4+ and CD8+ cells into the peritoneal cavity and increased IFN-γ levels in this initial site of virus replication. Studies with IFN-γ receptor knockout mice confirmed a role for IFN-γ in mediating the protective effect by LCMV-immune T cell populations when mice were challenged with VV but not PV. In some virus sequences memory cell populations, although clearing the challenge virus more rapidly, elicited enhanced IFN-γ–dependent immunopathogenesis in the form of acute fatty necrosis. These results indicate that how a host responds to an infectious agent is a function of its history of previous infections and their influence on the memory T cell pool.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453
Rickinson, A. (2001) · Virus Research · doi:10.1016/s0168-1702(01)00436-1 · Cited by 2,179
Taswell, C. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.126.4.1614 · Cited by 1,212
Induction of Bystander T Cell Proliferation by Viruses and Type I Interferon in Vivo
Tough, D. F., Borrow, P., & Sprent, J. (1996) · Science · doi:10.1126/science.272.5270.1947 · Cited by 1,077
KAPIKIAN, A. Z., MITCHELL, R. H., CHANOCK, R. M., SHVEDOFF, R. A., & STEWART, C. E. (1969) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a120954 · Cited by 1,033
Turnover of naive- and memory-phenotype T cells.
Tough, D. F., & Sprent, J. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1127 · Cited by 869 · cited 1×
“Some reports have suggested that memory T cells can be stimulated nonspecifically by cytokines (5, 6, 42), and may be cross-activated by an infection that does not require stimulation through their T cell receptor by cross-reactive viral peptides.”
BackgroundSarmiento, M., Glasebrook, A. L., & Fitch, F. W. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.125.6.2665 · Cited by 802
Pross, H. F., Baines, M. G., Rubin, P., Shragge, P., & Patterson, M. S. (1981) · Journal of Clinical Immunology · doi:10.1007/bf00915477 · Cited by 691
Cytotoxic T-cell memory without antigen
Lau, L. L., Jamieson, B. D., Somasundaram, T., & Ahmed, R. (1994) · Nature · doi:10.1038/369648a0 · Cited by 656
DISQUISITIONS ON ORIGINAL ANTIGENIC SIN
de St.Groth, S. F., & Webster, R. G. (1966) · The Journal of Experimental Medicine · doi:10.1084/jem.124.3.331 · Cited by 567
Cited by
Dengue Virus Pathogenesis: an Integrated View
Martina, B. E. E., Koraka, P., & Osterhaus, A. D. M. E. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00035-09 · Cited by 1,053
Epstein-Barr virus: exploiting the immune system
Thorley-Lawson, D. A. (2001) · Nature Reviews Immunology · doi:10.1038/35095584 · Cited by 939
Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever
Mongkolsapaya, J., Dejnirattisai, W., Xu, X.-N., Vasanawathana, S., Tangthawornchaikul, N., Chairunsri, A., Sawasdivorn, S., Duangchinda, T., Dong, T., Rowland-Jones, S., et al. (2003) · Nature Medicine · doi:10.1038/nm887 · Cited by 821
Clinical implications of dysregulated cytokine production
Slifka, M. K., & Whitton, J. L. (2000) · Journal of Molecular Medicine · doi:10.1007/s001090000086 · Cited by 655
Kleinnijenhuis, J., Quintin, J., Preijers, F., Benn, C. S., Joosten, L. A. B., Jacobs, C., van Loenhout, J., Xavier, R. J., Aaby, P., van der Meer, J. W. M., et al. (2014) · Journal of Innate Immunity · doi:10.1159/000355628 · Cited by 620
Heterologous immunity provides a potent barrier to transplantation tolerance
Adams, A. B., Williams, M. A., Jones, T. R., Shirasugi, N., Durham, M. M., Kaech, S. M., Wherry, E. J., Onami, T., Lanier, J. G., Kokko, K. E., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17477 · Cited by 617
Heterologous immunity provides a potent barrier to transplantation tolerance
Adams, A. B., Williams, M. A., Jones, T. R., Shirasugi, N., Durham, M. M., Kaech, S. M., Wherry, E. J., Onami, T., Lanier, J. G., Kokko, K. E., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317477 · Cited by 616
“Unfortunately, the heterologous response may also lead to immune-mediated disease in some circumstances (34, 35).”
BackgroundA small jab – a big effect: nonspecific immunomodulation by vaccines
Benn, C. S., Netea, M. G., Selin, L. K., & Aaby, P. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.04.004 · Cited by 514
Self-citationNo one is naive: the significance of heterologous T-cell immunity
Welsh, R. M., & Selin, L. K. (2002) · Nature Reviews Immunology · doi:10.1038/nri820 · Cited by 463
Self-citationDaniels, K. A., Devora, G., Lai, W. C., O'Donnell, C. L., Bennett, M., & Welsh, R. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.1.29 · Cited by 434
Self-citationDengue: defining protective versus pathologic immunity
Rothman, A. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421512 · Cited by 364
EBV Persistence—Introducing the Virus
Thorley-Lawson, D. A. (2015) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-319-22822-8_8 · Cited by 333
Heterologous immunity between viruses
Welsh, R. M., Che, J. W., Brehm, M. A., & Selin, L. K. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2010.00897.x · Cited by 292
Self-citationInhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathology
Hussell, T., Pennycook, A., & Openshaw, P. J. M. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200109)31:9<2566::aid-immu2566>3.0.co;2-l · Cited by 283
Selin, L. K., Lin, M. Y., Kraemer, K. A., Pardoll, D. M., Schneck, J. P., Varga, S. M., Santolucito, P. A., Pinto, A. K., & Welsh, R. M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80147-8 · Cited by 275
Self-citationDirect Antiviral Mechanisms of Interferon-Gamma
Kang, S., Brown, H. M., & Hwang, S. (2018) · Immune Network · doi:10.4110/in.2018.18.e33 · Cited by 272
Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung
Chen, H. D., Fraire, A. E., Joris, I., Brehm, M. A., Welsh, R. M., & Selin, L. K. (2001) · Nature Immunology · doi:10.1038/ni727 · Cited by 259
Self-citationT Cell Responses in Dengue Hemorrhagic Fever: Are Cross-Reactive T Cells Suboptimal?
Mongkolsapaya, J., Duangchinda, T., Dejnirattisai, W., Vasanawathana, S., Avirutnan, P., Jairungsri, A., Khemnu, N., Tangthawornchaikul, N., Chotiyarnwong, P., Sae-Jang, K., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.6.3821 · Cited by 258
Rapid on/off cycling of cytokine production by virus-specific CD8+ T cells
Slifka, M. K., Rodriguez, F., & Whitton, J. L. (1999) · Nature · doi:10.1038/43454 · Cited by 255
Immunodominant T-cell responses to dengue virus NS3 are associated with DHF
Duangchinda, T., Dejnirattisai, W., Vasanawathana, S., Limpitikul, W., Tangthawornchaikul, N., Malasit, P., Mongkolsapaya, J., & Screaton, G. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010867107 · Cited by 255
Molecular Mimicry in Multiple Sclerosis
Libbey, J. E., McCoy, L. L., & Fujinami, R. S. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(07)79006-2 · Cited by 102
Chen, H., Hou, J., Jiang, X., Ma, S., Meng, M., Wang, B., Zhang, M., Zhang, M., Tang, X., Zhang, F., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.591 · Cited by 75
“How a host responds to an infectious agent is a function of its history of previous infections and their influence on the memory T cell pool (41).”
Background
Metadata
- Authors
- Selin, L. K., Varga, S. M., Wong, I. C., & Welsh, R. M.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1998-11-02
- Volume
- 188
- Issue
- 9
- Pages
- 1705-1715
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2026973139
- Cited by
- 273
- References
- 46
- FWCI
- 3.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.